Company intelligence / Profile preview

Topaz Diagnostics

Ownership: Private
Development stage: Commercial

Overview

Topaz Diagnostics offers commercialized point-of-care rapid drug testing solutions using proprietary technology. Their products are designed for accuracy, reliability, and ease of use in healthcare environments focused on substance use prevention, treatment, harm reduction, and recovery. The company emphasizes customizable panels to meet specific facility needs.

Therapeutic areas: OtherPsychiatry
Modalities: DeviceDiagnostic test (urine and saliva-based rapid drug tests)
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Topaz Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Topaz Diagnostics.

Explore the full profile